nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—autonomic nervous system—type 2 diabetes mellitus	0.0432	0.221	CbGeAlD
Cysteamine—SST—peripheral nervous system—type 2 diabetes mellitus	0.0312	0.159	CbGeAlD
Cysteamine—SST—artery—type 2 diabetes mellitus	0.0245	0.125	CbGeAlD
Cysteamine—SST—nerve—type 2 diabetes mellitus	0.0243	0.124	CbGeAlD
Cysteamine—SST—islet of Langerhans—type 2 diabetes mellitus	0.0118	0.0601	CbGeAlD
Cysteamine—MPO—artery—type 2 diabetes mellitus	0.00988	0.0504	CbGeAlD
Cysteamine—SST—cardiovascular system—type 2 diabetes mellitus	0.00852	0.0435	CbGeAlD
Cysteamine—MPO—endothelium—type 2 diabetes mellitus	0.00834	0.0426	CbGeAlD
Cysteamine—SST—kidney—type 2 diabetes mellitus	0.00834	0.0425	CbGeAlD
Cysteamine—SST—pancreas—type 2 diabetes mellitus	0.00828	0.0423	CbGeAlD
Cysteamine—SST—liver—type 2 diabetes mellitus	0.00527	0.0269	CbGeAlD
Cysteamine—MPO—cardiovascular system—type 2 diabetes mellitus	0.00343	0.0175	CbGeAlD
Cysteamine—MPO—kidney—type 2 diabetes mellitus	0.00336	0.0171	CbGeAlD
Cysteamine—MPO—pancreas—type 2 diabetes mellitus	0.00334	0.017	CbGeAlD
Cysteamine—MPO—liver—type 2 diabetes mellitus	0.00212	0.0108	CbGeAlD
Cysteamine—Renal failure—Ramipril—type 2 diabetes mellitus	0.000557	0.00131	CcSEcCtD
Cysteamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000557	0.00131	CcSEcCtD
Cysteamine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000557	0.00131	CcSEcCtD
Cysteamine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000556	0.00131	CcSEcCtD
Cysteamine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000551	0.0013	CcSEcCtD
Cysteamine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00055	0.00129	CcSEcCtD
Cysteamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000549	0.00129	CcSEcCtD
Cysteamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000549	0.00129	CcSEcCtD
Cysteamine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000549	0.00129	CcSEcCtD
Cysteamine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000549	0.00129	CcSEcCtD
Cysteamine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000548	0.00129	CcSEcCtD
Cysteamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000547	0.00129	CcSEcCtD
Cysteamine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000547	0.00128	CcSEcCtD
Cysteamine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000547	0.00128	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000546	0.00128	CcSEcCtD
Cysteamine—Tremor—Metformin—type 2 diabetes mellitus	0.000545	0.00128	CcSEcCtD
Cysteamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000543	0.00128	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00054	0.00127	CcSEcCtD
Cysteamine—Tension—Irbesartan—type 2 diabetes mellitus	0.000539	0.00127	CcSEcCtD
Cysteamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000538	0.00126	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000534	0.00125	CcSEcCtD
Cysteamine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000533	0.00125	CcSEcCtD
Cysteamine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000531	0.00125	CcSEcCtD
Cysteamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000524	0.00123	CcSEcCtD
Cysteamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000523	0.00123	CcSEcCtD
Cysteamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000522	0.00123	CcSEcCtD
Cysteamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000521	0.00123	CcSEcCtD
Cysteamine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000521	0.00122	CcSEcCtD
Cysteamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00052	0.00122	CcSEcCtD
Cysteamine—Rash—Glipizide—type 2 diabetes mellitus	0.000518	0.00122	CcSEcCtD
Cysteamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000517	0.00122	CcSEcCtD
Cysteamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000517	0.00121	CcSEcCtD
Cysteamine—Erythema—Losartan—type 2 diabetes mellitus	0.000517	0.00121	CcSEcCtD
Cysteamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000515	0.00121	CcSEcCtD
Cysteamine—Headache—Glipizide—type 2 diabetes mellitus	0.000515	0.00121	CcSEcCtD
Cysteamine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000514	0.00121	CcSEcCtD
Cysteamine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000511	0.0012	CcSEcCtD
Cysteamine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000508	0.00119	CcSEcCtD
Cysteamine—Tension—Losartan—type 2 diabetes mellitus	0.000507	0.00119	CcSEcCtD
Cysteamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000507	0.00119	CcSEcCtD
Cysteamine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000507	0.00119	CcSEcCtD
Cysteamine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000505	0.00119	CcSEcCtD
Cysteamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000505	0.00119	CcSEcCtD
Cysteamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000505	0.00119	CcSEcCtD
Cysteamine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000505	0.00119	CcSEcCtD
Cysteamine—Hypertension—Metformin—type 2 diabetes mellitus	0.000502	0.00118	CcSEcCtD
Cysteamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000502	0.00118	CcSEcCtD
Cysteamine—Nervousness—Losartan—type 2 diabetes mellitus	0.000502	0.00118	CcSEcCtD
Cysteamine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000501	0.00118	CcSEcCtD
Cysteamine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.0005	0.00118	CcSEcCtD
Cysteamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.0005	0.00117	CcSEcCtD
Cysteamine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.0005	0.00117	CcSEcCtD
Cysteamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000497	0.00117	CcSEcCtD
Cysteamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000496	0.00117	CcSEcCtD
Cysteamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000493	0.00116	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000492	0.00116	CcSEcCtD
Cysteamine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000492	0.00115	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00049	0.00115	CcSEcCtD
Cysteamine—Discomfort—Metformin—type 2 diabetes mellitus	0.000489	0.00115	CcSEcCtD
Cysteamine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000489	0.00115	CcSEcCtD
Cysteamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000488	0.00115	CcSEcCtD
Cysteamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000487	0.00115	CcSEcCtD
Cysteamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000486	0.00114	CcSEcCtD
Cysteamine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000485	0.00114	CcSEcCtD
Cysteamine—Tremor—Losartan—type 2 diabetes mellitus	0.000484	0.00114	CcSEcCtD
Cysteamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000483	0.00114	CcSEcCtD
Cysteamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000483	0.00113	CcSEcCtD
Cysteamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000482	0.00113	CcSEcCtD
Cysteamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000481	0.00113	CcSEcCtD
Cysteamine—Headache—Glimepiride—type 2 diabetes mellitus	0.00048	0.00113	CcSEcCtD
Cysteamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000479	0.00112	CcSEcCtD
Cysteamine—Anaemia—Losartan—type 2 diabetes mellitus	0.000478	0.00112	CcSEcCtD
Cysteamine—Agitation—Losartan—type 2 diabetes mellitus	0.000475	0.00112	CcSEcCtD
Cysteamine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000474	0.00111	CcSEcCtD
Cysteamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000473	0.00111	CcSEcCtD
Cysteamine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000468	0.0011	CcSEcCtD
Cysteamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000466	0.00109	CcSEcCtD
Cysteamine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000466	0.00109	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000464	0.00109	CcSEcCtD
Cysteamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000464	0.00109	CcSEcCtD
Cysteamine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000464	0.00109	CcSEcCtD
Cysteamine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000463	0.00109	CcSEcCtD
Cysteamine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000462	0.00109	CcSEcCtD
Cysteamine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000461	0.00108	CcSEcCtD
Cysteamine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00046	0.00108	CcSEcCtD
Cysteamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000459	0.00108	CcSEcCtD
Cysteamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000457	0.00107	CcSEcCtD
Cysteamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000455	0.00107	CcSEcCtD
Cysteamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000454	0.00107	CcSEcCtD
Cysteamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000454	0.00107	CcSEcCtD
Cysteamine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000454	0.00107	CcSEcCtD
Cysteamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000453	0.00107	CcSEcCtD
Cysteamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000453	0.00106	CcSEcCtD
Cysteamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000451	0.00106	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00045	0.00106	CcSEcCtD
Cysteamine—Fatigue—Valsartan—type 2 diabetes mellitus	0.00045	0.00106	CcSEcCtD
Cysteamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000449	0.00105	CcSEcCtD
Cysteamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000449	0.00105	CcSEcCtD
Cysteamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000448	0.00105	CcSEcCtD
Cysteamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000448	0.00105	CcSEcCtD
Cysteamine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000446	0.00105	CcSEcCtD
Cysteamine—Constipation—Valsartan—type 2 diabetes mellitus	0.000446	0.00105	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000445	0.00105	CcSEcCtD
Cysteamine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000444	0.00104	CcSEcCtD
Cysteamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000443	0.00104	CcSEcCtD
Cysteamine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000443	0.00104	CcSEcCtD
Cysteamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00044	0.00103	CcSEcCtD
Cysteamine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000439	0.00103	CcSEcCtD
Cysteamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000436	0.00102	CcSEcCtD
Cysteamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000436	0.00102	CcSEcCtD
Cysteamine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000435	0.00102	CcSEcCtD
Cysteamine—Tension—Ramipril—type 2 diabetes mellitus	0.000435	0.00102	CcSEcCtD
Cysteamine—Discomfort—Losartan—type 2 diabetes mellitus	0.000435	0.00102	CcSEcCtD
Cysteamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000433	0.00102	CcSEcCtD
Cysteamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000432	0.00102	CcSEcCtD
Cysteamine—Nervousness—Ramipril—type 2 diabetes mellitus	0.00043	0.00101	CcSEcCtD
Cysteamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000427	0.001	CcSEcCtD
Cysteamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000426	0.001	CcSEcCtD
Cysteamine—Confusional state—Losartan—type 2 diabetes mellitus	0.000425	0.000999	CcSEcCtD
Cysteamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000425	0.000998	CcSEcCtD
Cysteamine—Somnolence—Metformin—type 2 diabetes mellitus	0.000422	0.000992	CcSEcCtD
Cysteamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000422	0.000991	CcSEcCtD
Cysteamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000421	0.00099	CcSEcCtD
Cysteamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000418	0.000983	CcSEcCtD
Cysteamine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000418	0.000982	CcSEcCtD
Cysteamine—Tremor—Ramipril—type 2 diabetes mellitus	0.000415	0.000975	CcSEcCtD
Cysteamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000414	0.000973	CcSEcCtD
Cysteamine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000414	0.000972	CcSEcCtD
Cysteamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000413	0.00097	CcSEcCtD
Cysteamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000412	0.000969	CcSEcCtD
Cysteamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000411	0.000965	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00041	0.000963	CcSEcCtD
Cysteamine—Fatigue—Metformin—type 2 diabetes mellitus	0.000409	0.000962	CcSEcCtD
Cysteamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000409	0.000962	CcSEcCtD
Cysteamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000407	0.000957	CcSEcCtD
Cysteamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000407	0.000957	CcSEcCtD
Cysteamine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000407	0.000957	CcSEcCtD
Cysteamine—Agitation—Ramipril—type 2 diabetes mellitus	0.000407	0.000957	CcSEcCtD
Cysteamine—Constipation—Metformin—type 2 diabetes mellitus	0.000406	0.000954	CcSEcCtD
Cysteamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000402	0.000945	CcSEcCtD
Cysteamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000402	0.000944	CcSEcCtD
Cysteamine—Rash—Glyburide—type 2 diabetes mellitus	0.000399	0.000936	CcSEcCtD
Cysteamine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000398	0.000936	CcSEcCtD
Cysteamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000398	0.000936	CcSEcCtD
Cysteamine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000397	0.000932	CcSEcCtD
Cysteamine—Headache—Glyburide—type 2 diabetes mellitus	0.000396	0.00093	CcSEcCtD
Cysteamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000394	0.000927	CcSEcCtD
Cysteamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000391	0.000919	CcSEcCtD
Cysteamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00039	0.000915	CcSEcCtD
Cysteamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000388	0.000912	CcSEcCtD
Cysteamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000388	0.000912	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000387	0.000909	CcSEcCtD
Cysteamine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000386	0.000908	CcSEcCtD
Cysteamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000384	0.000903	CcSEcCtD
Cysteamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000384	0.000902	CcSEcCtD
Cysteamine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000383	0.0009	CcSEcCtD
Cysteamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00038	0.000892	CcSEcCtD
Cysteamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000377	0.000886	CcSEcCtD
Cysteamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000375	0.000882	CcSEcCtD
Cysteamine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000375	0.000882	CcSEcCtD
Cysteamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000375	0.000882	CcSEcCtD
Cysteamine—Somnolence—Losartan—type 2 diabetes mellitus	0.000375	0.000881	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000375	0.00088	CcSEcCtD
Cysteamine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000374	0.000879	CcSEcCtD
Cysteamine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000373	0.000876	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000372	0.000984	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000372	0.000983	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000372	0.000983	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	0.000372	0.000982	CbGpPWpGaD
Cysteamine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000371	0.000872	CcSEcCtD
Cysteamine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00037	0.000869	CcSEcCtD
Cysteamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000369	0.000868	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000368	0.000972	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000368	0.000972	CbGpPWpGaD
Cysteamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000367	0.000861	CcSEcCtD
Cysteamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000366	0.000861	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000366	0.000967	CbGpPWpGaD
Cysteamine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000365	0.000857	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000364	0.000961	CbGpPWpGaD
Cysteamine—Fatigue—Losartan—type 2 diabetes mellitus	0.000364	0.000854	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000362	0.000957	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000362	0.00085	CcSEcCtD
Cysteamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000361	0.000848	CcSEcCtD
Cysteamine—Constipation—Losartan—type 2 diabetes mellitus	0.000361	0.000847	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000359	0.000949	CbGpPWpGaD
Cysteamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000358	0.000841	CcSEcCtD
Cysteamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000358	0.00084	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000357	0.000944	CbGpPWpGaD
Cysteamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000357	0.000838	CcSEcCtD
Cysteamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000356	0.000836	CcSEcCtD
Cysteamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000356	0.000835	CcSEcCtD
Cysteamine—SST—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000355	0.000937	CbGpPWpGaD
Cysteamine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000355	0.000833	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000355	0.000937	CbGpPWpGaD
Cysteamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000354	0.000832	CcSEcCtD
Cysteamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000354	0.000832	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000353	0.000933	CbGpPWpGaD
Cysteamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000353	0.000828	CcSEcCtD
Cysteamine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000351	0.000825	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000351	0.000927	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000349	0.000922	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000349	0.000922	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000348	0.000921	CbGpPWpGaD
Cysteamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000348	0.000817	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000347	0.000918	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000345	0.00081	CcSEcCtD
Cysteamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000345	0.00081	CcSEcCtD
Cysteamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000345	0.00081	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000341	0.000902	CbGpPWpGaD
Cysteamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000341	0.000801	CcSEcCtD
Cysteamine—Asthenia—Metformin—type 2 diabetes mellitus	0.000341	0.000801	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.00034	0.000899	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.00034	0.000898	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000339	0.000894	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000338	0.000894	CbGpPWpGaD
Cysteamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000337	0.000792	CcSEcCtD
Cysteamine—Urticaria—Losartan—type 2 diabetes mellitus	0.000335	0.000787	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000334	0.000884	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000334	0.000883	CbGpPWpGaD
Cysteamine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000333	0.000783	CcSEcCtD
Cysteamine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000333	0.000783	CcSEcCtD
Cysteamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000332	0.000779	CcSEcCtD
Cysteamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00033	0.000776	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000329	0.000869	CbGpPWpGaD
Cysteamine—Rash—Valsartan—type 2 diabetes mellitus	0.000329	0.000773	CcSEcCtD
Cysteamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000328	0.000772	CcSEcCtD
Cysteamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000328	0.00077	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000327	0.000865	CbGpPWpGaD
Cysteamine—Headache—Valsartan—type 2 diabetes mellitus	0.000327	0.000768	CcSEcCtD
Cysteamine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000325	0.000763	CcSEcCtD
Cysteamine—Rash—Orlistat—type 2 diabetes mellitus	0.000325	0.000763	CcSEcCtD
Cysteamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000325	0.000763	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000324	0.000857	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000324	0.000857	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000323	0.000853	CbGpPWpGaD
Cysteamine—Headache—Orlistat—type 2 diabetes mellitus	0.000323	0.000758	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000322	0.000852	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000322	0.000851	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000322	0.00085	CbGpPWpGaD
Cysteamine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000322	0.000755	CcSEcCtD
Cysteamine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000321	0.000755	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000321	0.000847	CbGpPWpGaD
Cysteamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000318	0.000748	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000318	0.000839	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000317	0.000837	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000316	0.000835	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—type 2 diabetes mellitus	0.000316	0.000834	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000315	0.000833	CbGpPWpGaD
Cysteamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000314	0.000739	CcSEcCtD
Cysteamine—Dizziness—Metformin—type 2 diabetes mellitus	0.000314	0.000738	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	0.000313	0.000828	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000312	0.000734	CcSEcCtD
Cysteamine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000312	0.000733	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000311	0.000822	CbGpPWpGaD
Cysteamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000311	0.00073	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.00031	0.000819	CbGpPWpGaD
Cysteamine—Nausea—Valsartan—type 2 diabetes mellitus	0.00031	0.000728	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.00031	0.000818	CbGpPWpGaD
Cysteamine—Constipation—Ramipril—type 2 diabetes mellitus	0.000309	0.000727	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000309	0.000816	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000307	0.000812	CbGpPWpGaD
Cysteamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000307	0.00072	CcSEcCtD
Cysteamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000306	0.000719	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000305	0.000805	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000304	0.000802	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000303	0.0008	CbGpPWpGaD
Cysteamine—Asthenia—Losartan—type 2 diabetes mellitus	0.000303	0.000711	CcSEcCtD
Cysteamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000302	0.000709	CcSEcCtD
Cysteamine—SST—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000302	0.000797	CbGpPWpGaD
Cysteamine—Rash—Metformin—type 2 diabetes mellitus	0.000299	0.000704	CcSEcCtD
Cysteamine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000299	0.000703	CcSEcCtD
Cysteamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000298	0.0007	CcSEcCtD
Cysteamine—Headache—Metformin—type 2 diabetes mellitus	0.000297	0.000699	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000297	0.000785	CbGpPWpGaD
Cysteamine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000296	0.000696	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000296	0.000695	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000293	0.000775	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.00029	0.000767	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000289	0.000764	CbGpPWpGaD
Cysteamine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000289	0.000678	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000289	0.000762	CbGpPWpGaD
Cysteamine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000287	0.000675	CcSEcCtD
Cysteamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000286	0.000672	CcSEcCtD
Cysteamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000286	0.000672	CcSEcCtD
Cysteamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000285	0.000669	CcSEcCtD
Cysteamine—Rash—Irbesartan—type 2 diabetes mellitus	0.000283	0.000664	CcSEcCtD
Cysteamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000282	0.000663	CcSEcCtD
Cysteamine—Nausea—Metformin—type 2 diabetes mellitus	0.000282	0.000663	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000281	0.000743	CbGpPWpGaD
Cysteamine—Headache—Irbesartan—type 2 diabetes mellitus	0.000281	0.00066	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.00028	0.000741	CbGpPWpGaD
Cysteamine—Dizziness—Losartan—type 2 diabetes mellitus	0.000279	0.000655	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000278	0.000735	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000278	0.000735	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000277	0.000731	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000275	0.000726	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000269	0.00071	CbGpPWpGaD
Cysteamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000268	0.00063	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000267	0.000705	CbGpPWpGaD
Cysteamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000266	0.000626	CcSEcCtD
Cysteamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000266	0.000625	CcSEcCtD
Cysteamine—Rash—Losartan—type 2 diabetes mellitus	0.000266	0.000625	CcSEcCtD
Cysteamine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000266	0.000624	CcSEcCtD
Cysteamine—Headache—Losartan—type 2 diabetes mellitus	0.000264	0.000621	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000263	0.000696	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000261	0.00069	CbGpPWpGaD
Cysteamine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000259	0.00061	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000259	0.000684	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000256	0.000678	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000256	0.000678	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—type 2 diabetes mellitus	0.000255	0.000673	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000253	0.000668	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—type 2 diabetes mellitus	0.000252	0.000665	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.000251	0.000663	CbGpPWpGaD
Cysteamine—Nausea—Losartan—type 2 diabetes mellitus	0.000251	0.000589	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00025	0.000662	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00025	0.00066	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00025	0.00066	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000249	0.000659	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000249	0.000659	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000248	0.000656	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000248	0.000655	CbGpPWpGaD
Cysteamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000247	0.000581	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000246	0.00065	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000246	0.00065	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000246	0.00065	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000242	0.00064	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00024	0.000633	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00024	0.000633	CbGpPWpGaD
Cysteamine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000239	0.000562	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000239	0.000632	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000239	0.000632	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000238	0.000628	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000237	0.000627	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000236	0.000623	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000233	0.000617	CbGpPWpGaD
Cysteamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00023	0.00054	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000228	0.000603	CbGpPWpGaD
Cysteamine—Rash—Ramipril—type 2 diabetes mellitus	0.000228	0.000536	CcSEcCtD
Cysteamine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000228	0.000535	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000227	0.000601	CbGpPWpGaD
Cysteamine—Headache—Ramipril—type 2 diabetes mellitus	0.000227	0.000532	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000225	0.000595	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000224	0.000591	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000223	0.000589	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000221	0.000585	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INSR—type 2 diabetes mellitus	0.00022	0.000581	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000219	0.000578	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000217	0.000573	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000216	0.000571	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000216	0.000571	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000216	0.00057	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000215	0.000568	CbGpPWpGaD
Cysteamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000215	0.000505	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000214	0.000564	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000212	0.000561	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000212	0.00056	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000211	0.000557	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000208	0.000549	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000207	0.000548	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000207	0.000547	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000207	0.000547	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000206	0.000544	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000206	0.000544	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000203	0.000537	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	0.000202	0.000535	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.0002	0.000529	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.0002	0.000528	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.0002	0.000528	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000199	0.000525	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000197	0.000521	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000197	0.00052	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000194	0.000514	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000194	0.000511	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000194	0.000511	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000192	0.000507	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000192	0.000506	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000192	0.000506	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00019	0.000503	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000189	0.0005	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000189	0.0005	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000189	0.000499	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000187	0.000494	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000186	0.000492	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000186	0.00049	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000186	0.00049	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000182	0.000482	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000182	0.000481	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000182	0.00048	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000182	0.00048	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000179	0.000474	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000176	0.000466	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000175	0.000463	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000174	0.000461	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000173	0.000458	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000173	0.000458	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.00017	0.00045	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.00017	0.000449	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000169	0.000446	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000168	0.000444	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000166	0.000439	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000166	0.000439	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000163	0.000432	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000163	0.00043	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000162	0.000428	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000159	0.000421	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000159	0.00042	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000155	0.000411	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000153	0.000403	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000153	0.000403	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000151	0.000398	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000149	0.000395	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000147	0.000389	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000147	0.000389	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000147	0.000387	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000146	0.000386	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000145	0.000382	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000144	0.000382	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000143	0.000378	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000142	0.000376	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000142	0.000375	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000141	0.000373	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000141	0.000373	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000141	0.000372	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.00014	0.00037	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.00014	0.00037	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000139	0.000366	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000136	0.000361	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000136	0.000359	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000136	0.000359	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000134	0.000355	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000133	0.000352	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LPL—type 2 diabetes mellitus	0.00013	0.000344	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000128	0.000337	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000128	0.000337	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000125	0.000331	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—C3—type 2 diabetes mellitus	0.000122	0.000323	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000122	0.000323	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.00012	0.000317	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—C3—type 2 diabetes mellitus	0.000117	0.00031	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000117	0.000308	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000116	0.000308	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000116	0.000307	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000114	0.000302	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000114	0.000301	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000114	0.000301	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000113	0.000298	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000112	0.000296	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000112	0.000295	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000111	0.000295	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.00011	0.00029	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000109	0.000289	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000109	0.000289	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000108	0.000285	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000107	0.000284	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000103	0.000272	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000102	0.000269	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.75e-05	0.000258	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INS—type 2 diabetes mellitus	9.73e-05	0.000257	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.58e-05	0.000253	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.42e-05	0.000249	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.41e-05	0.000249	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.37e-05	0.000248	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INS—type 2 diabetes mellitus	9.33e-05	0.000247	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.18e-05	0.000243	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.03e-05	0.000239	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.02e-05	0.000238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.98e-05	0.000237	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.94e-05	0.000236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.57e-05	0.000227	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.54e-05	0.000226	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.54e-05	0.000226	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.18e-05	0.000216	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.18e-05	0.000216	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RELA—type 2 diabetes mellitus	8.04e-05	0.000212	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RELA—type 2 diabetes mellitus	7.7e-05	0.000204	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.31e-05	0.000193	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.25e-05	0.000191	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.2e-05	0.00019	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.01e-05	0.000185	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.95e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.9e-05	0.000182	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.85e-05	0.000181	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.78e-05	0.000179	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.64e-05	0.000176	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.57e-05	0.000174	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.5e-05	0.000172	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.37e-05	0.000168	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—type 2 diabetes mellitus	6.31e-05	0.000167	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.15e-05	0.000163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—type 2 diabetes mellitus	6.05e-05	0.00016	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.9e-05	0.000156	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.64e-05	0.000149	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.53e-05	0.000146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.41e-05	0.000143	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.31e-05	0.00014	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—type 2 diabetes mellitus	4.25e-05	0.000112	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—type 2 diabetes mellitus	4.08e-05	0.000108	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.92e-05	0.000104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.76e-05	9.94e-05	CbGpPWpGaD
